The biopharmaceutical company reported ($0.02) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.01), Zacks reports. Geron Stock Up 21.6%Shares of NASDAQ:GERN traded up $0.29 during trading on Wednesday, hitting $1.63. RA Capital Management L.P. raised its position in Geron by 5.6% during the fourth quarter. Vestal Point Capital LP raised its holdings in shares of Geron by 8.0% in the 2nd quarter. Soleus Capital Management L.P. lifted its stake in Geron by 572.5% in the 2nd quarter.